agilon health (NYSE:AGL – Get Free Report) was downgraded by analysts at JMP Securities from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Monday, Marketbeat.com reports.
Other analysts have also issued reports about the company. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Evercore ISI cut their price target on agilon health from $7.00 to $4.00 and set an “in-line” rating for the company in a research note on Tuesday, October 8th. Bank of America cut agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research note on Wednesday, October 2nd. Benchmark reaffirmed a “buy” rating and set a $9.00 price objective on shares of agilon health in a research report on Thursday, August 8th. Finally, Citigroup reiterated a “sell” rating and issued a $2.50 target price (down from $7.00) on shares of agilon health in a research note on Tuesday, October 29th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $7.03.
Check Out Our Latest Analysis on AGL
agilon health Price Performance
agilon health (NYSE:AGL – Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 46.06%. During the same quarter in the prior year, the company posted ($0.06) EPS. Equities research analysts expect that agilon health will post -0.32 EPS for the current fiscal year.
Insider Activity at agilon health
In other agilon health news, CEO Steven Sell bought 20,000 shares of the stock in a transaction on Thursday, September 12th. The shares were purchased at an average price of $3.36 per share, with a total value of $67,200.00. Following the acquisition, the chief executive officer now directly owns 67,590 shares of the company’s stock, valued at $227,102.40. This represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 3.20% of the stock is owned by corporate insiders.
Institutional Trading of agilon health
A number of hedge funds have recently bought and sold shares of AGL. J.Safra Asset Management Corp lifted its stake in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the period. City State Bank bought a new position in agilon health during the third quarter valued at about $52,000. CWM LLC raised its holdings in agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after acquiring an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC acquired a new stake in shares of agilon health during the 2nd quarter worth approximately $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in shares of agilon health during the 1st quarter worth approximately $65,000.
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than agilon health
- About the Markup Calculator
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- What is the S&P 500 and How It is Distinct from Other Indexes
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What Are Dividend Champions? How to Invest in the Champions
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.